CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
The Parkinson’s Progression Marker Initiative(University of Pennsylvania), Ju‐Hee Kang(Inha University), Brit Mollenhauer(University of Iowa), Christopher S. Coffey(University of Iowa), Jon B. Toledo(Institute on Aging), Daniel Weintraub(University of California San Diego), Douglas Galasko(University of California San Diego), David J. Irwin(Institute on Aging), Vivianna M. Van Deerlin(Institute on Aging), Alice Chen‐Plotkin(University of Iowa), Chelsea Caspell‐Garcia(University of Iowa), Teresa Waligórska(BioLegend (United States)), Peggy Taylor(BioLegend (United States)), Nirali Shah(University of Pennsylvania), Sarah Pan(University of Pennsylvania), Paweł Żero(Michael J. Fox Foundation), Mark Frasier(Michael J. Fox Foundation), Kenneth Marek(Institute for Neurodegenerative Disorders), Karl Kieburtz(Institute for Neurodegenerative Disorders), Danna Jennings(San Francisco VA Medical Center), Caroline M. Tanner(Northwestern University), Tanya Simuni(Northwestern University), Andrew Singleton(University of Southern California), Arthur W. Toga(University of Southern California), Sohini Chowdhury(Michael J. Fox Foundation), John Q. Trojanowski(Institute on Aging), Leslie M. Shaw(Institute on Aging)
Cited by 219Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis